Report Detail

Request for Sample of this report

Pharma & Healthcare Global Vitamin K Antagonists (VKA) Market Insights and Forecast to 2026

  • RnM4147223
    • |
  • 19 August, 2020
    • |
  • Global
    • |
  • 116 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

Vitamin K Antagonists (VKA) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vitamin K Antagonists (VKA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Vitamin K Antagonists (VKA) market is segmented into
Oral Vitamin K Antagonists
Injection Vitamin K Antagonists

Segment by Application, the Vitamin K Antagonists (VKA) market is segmented into
VTE
ACS/MI
AF
Others

Regional and Country-level Analysis
The Vitamin K Antagonists (VKA) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Vitamin K Antagonists (VKA) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vitamin K Antagonists (VKA) Market Share Analysis
Vitamin K Antagonists (VKA) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vitamin K Antagonists (VKA) business, the date to enter into the Vitamin K Antagonists (VKA) market, Vitamin K Antagonists (VKA) product introduction, recent developments, etc.

The major vendors covered:
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company


1 Study Coverage

  • 1.1 Vitamin K Antagonists (VKA) Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Vitamin K Antagonists (VKA) Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Type
    • 1.4.2 Oral Vitamin K Antagonists
    • 1.4.3 Injection Vitamin K Antagonists
  • 1.5 Market by Application
    • 1.5.1 Global Vitamin K Antagonists (VKA) Market Size Growth Rate by Application
    • 1.5.2 VTE
    • 1.5.3 ACS/MI
    • 1.5.4 AF
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Vitamin K Antagonists (VKA) Market Size, Estimates and Forecasts
    • 2.1.1 Global Vitamin K Antagonists (VKA) Revenue 2015-2026
    • 2.1.2 Global Vitamin K Antagonists (VKA) Sales 2015-2026
  • 2.2 Global Vitamin K Antagonists (VKA), Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Vitamin K Antagonists (VKA) Competitor Landscape by Players

  • 3.1 Vitamin K Antagonists (VKA) Sales by Manufacturers
    • 3.1.1 Vitamin K Antagonists (VKA) Sales by Manufacturers (2015-2020)
    • 3.1.2 Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Vitamin K Antagonists (VKA) Revenue by Manufacturers
    • 3.2.1 Vitamin K Antagonists (VKA) Revenue by Manufacturers (2015-2020)
    • 3.2.2 Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Vitamin K Antagonists (VKA) Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Vitamin K Antagonists (VKA) Revenue in 2019
    • 3.2.5 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Vitamin K Antagonists (VKA) Price by Manufacturers
  • 3.4 Vitamin K Antagonists (VKA) Manufacturing Base Distribution, Product Types
    • 3.4.1 Vitamin K Antagonists (VKA) Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Vitamin K Antagonists (VKA) Product Type
    • 3.4.3 Date of International Manufacturers Enter into Vitamin K Antagonists (VKA) Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Vitamin K Antagonists (VKA) Market Size by Type (2015-2020)
    • 4.1.1 Global Vitamin K Antagonists (VKA) Sales by Type (2015-2020)
    • 4.1.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2015-2020)
    • 4.1.3 Vitamin K Antagonists (VKA) Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Vitamin K Antagonists (VKA) Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Type (2021-2026)
    • 4.2.3 Vitamin K Antagonists (VKA) Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Vitamin K Antagonists (VKA) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Vitamin K Antagonists (VKA) Market Size by Application (2015-2020)
    • 5.1.1 Global Vitamin K Antagonists (VKA) Sales by Application (2015-2020)
    • 5.1.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2015-2020)
    • 5.1.3 Vitamin K Antagonists (VKA) Price by Application (2015-2020)
  • 5.2 Vitamin K Antagonists (VKA) Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Vitamin K Antagonists (VKA) Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Vitamin K Antagonists (VKA) by Country
    • 6.1.1 North America Vitamin K Antagonists (VKA) Sales by Country
    • 6.1.2 North America Vitamin K Antagonists (VKA) Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Type
  • 6.3 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Vitamin K Antagonists (VKA) by Country
    • 7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Country
    • 7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Type
  • 7.3 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Vitamin K Antagonists (VKA) by Region
    • 8.1.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region
    • 8.1.2 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Type
  • 8.3 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Vitamin K Antagonists (VKA) by Country
    • 9.1.1 Latin America Vitamin K Antagonists (VKA) Sales by Country
    • 9.1.2 Latin America Vitamin K Antagonists (VKA) Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Vitamin K Antagonists (VKA) Market Facts & Figures by Type
  • 9.3 Central & South America Vitamin K Antagonists (VKA) Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Vitamin K Antagonists (VKA) by Country
    • 10.1.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country
    • 10.1.2 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Type
  • 10.3 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description and Business Overview
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
    • 11.1.5 Sanofi Related Developments
  • 11.2 Bristol-Myers Squibb
    • 11.2.1 Bristol-Myers Squibb Corporation Information
    • 11.2.2 Bristol-Myers Squibb Description and Business Overview
    • 11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Products Offered
    • 11.2.5 Bristol-Myers Squibb Related Developments
  • 11.3 Bayer
    • 11.3.1 Bayer Corporation Information
    • 11.3.2 Bayer Description and Business Overview
    • 11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bayer Vitamin K Antagonists (VKA) Products Offered
    • 11.3.5 Bayer Related Developments
  • 11.4 Johnson & Johnson
    • 11.4.1 Johnson & Johnson Corporation Information
    • 11.4.2 Johnson & Johnson Description and Business Overview
    • 11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Products Offered
    • 11.4.5 Johnson & Johnson Related Developments
  • 11.5 Genentech (Roche)
    • 11.5.1 Genentech (Roche) Corporation Information
    • 11.5.2 Genentech (Roche) Description and Business Overview
    • 11.5.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Products Offered
    • 11.5.5 Genentech (Roche) Related Developments
  • 11.6 Boehringer Ingelheim
    • 11.6.1 Boehringer Ingelheim Corporation Information
    • 11.6.2 Boehringer Ingelheim Description and Business Overview
    • 11.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Products Offered
    • 11.6.5 Boehringer Ingelheim Related Developments
  • 11.7 Lilly
    • 11.7.1 Lilly Corporation Information
    • 11.7.2 Lilly Description and Business Overview
    • 11.7.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Lilly Vitamin K Antagonists (VKA) Products Offered
    • 11.7.5 Lilly Related Developments
  • 11.8 Daiichi Sankyo
    • 11.8.1 Daiichi Sankyo Corporation Information
    • 11.8.2 Daiichi Sankyo Description and Business Overview
    • 11.8.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Products Offered
    • 11.8.5 Daiichi Sankyo Related Developments
  • 11.9 Otsuka
    • 11.9.1 Otsuka Corporation Information
    • 11.9.2 Otsuka Description and Business Overview
    • 11.9.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Otsuka Vitamin K Antagonists (VKA) Products Offered
    • 11.9.5 Otsuka Related Developments
  • 11.10 AstraZeneca
    • 11.10.1 AstraZeneca Corporation Information
    • 11.10.2 AstraZeneca Description and Business Overview
    • 11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 AstraZeneca Vitamin K Antagonists (VKA) Products Offered
    • 11.10.5 AstraZeneca Related Developments
  • 11.1 Sanofi
    • 11.1.1 Sanofi Corporation Information
    • 11.1.2 Sanofi Description and Business Overview
    • 11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Sanofi Vitamin K Antagonists (VKA) Products Offered
    • 11.1.5 Sanofi Related Developments
  • 11.12 Aspen
    • 11.12.1 Aspen Corporation Information
    • 11.12.2 Aspen Description and Business Overview
    • 11.12.3 Aspen Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Aspen Products Offered
    • 11.12.5 Aspen Related Developments
  • 11.13 The Medicines Company
    • 11.13.1 The Medicines Company Corporation Information
    • 11.13.2 The Medicines Company Description and Business Overview
    • 11.13.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 The Medicines Company Products Offered
    • 11.13.5 The Medicines Company Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Vitamin K Antagonists (VKA) Market Estimates and Projections by Region
    • 12.1.1 Global Vitamin K Antagonists (VKA) Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Vitamin K Antagonists (VKA) Revenue Forecast by Regions 2021-2026
  • 12.2 North America Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
    • 12.2.1 North America: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
    • 12.2.2 North America: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
    • 12.2.3 North America: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
    • 12.3.2 Europe: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Vitamin K Antagonists (VKA) Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Vitamin K Antagonists (VKA) Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Vitamin K Antagonists (VKA) Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Vitamin K Antagonists (VKA) Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Vitamin K Antagonists (VKA) Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Vitamin K Antagonists (VKA) Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Vitamin K Antagonists (VKA) Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Vitamin K Antagonists (VKA). Industry analysis & Market Report on Vitamin K Antagonists (VKA) is a syndicated market report, published as Global Vitamin K Antagonists (VKA) Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Vitamin K Antagonists (VKA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,108.30
    		4,662.45
    		6,216.60
    		3,638.70
    		5,458.05
    		7,277.40
    		609,414.00
    		914,121.00
    		1,218,828.00
    		325,533.00
    		488,299.50
    		651,066.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo